SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Free Report) - Zacks Small Cap issued their Q3 2024 earnings per share (EPS) estimates for shares of SBC Medical Group in a research report issued on Wednesday, October 23rd. Zacks Small Cap analyst M. Marin anticipates that the company will post earnings per share of $2.36 for the quarter. Zacks Small Cap also issued estimates for SBC Medical Group's Q4 2024 earnings at $2.41 EPS, FY2024 earnings at $9.46 EPS and FY2025 earnings at $10.50 EPS.
SBC Medical Group Trading Down 2.3 %
NASDAQ:SBC traded down $0.17 during trading hours on Friday, reaching $7.15. 24,009 shares of the company traded hands, compared to its average volume of 43,452. SBC Medical Group has a 1-year low of $5.30 and a 1-year high of $36.52.
About SBC Medical Group
(
Get Free Report)
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.
Read More
Before you consider SBC Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SBC Medical Group wasn't on the list.
While SBC Medical Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
